Minne Casteels

769 total citations
22 papers, 559 citations indexed

About

Minne Casteels is a scholar working on Geriatrics and Gerontology, Molecular Biology and Physiology. According to data from OpenAlex, Minne Casteels has authored 22 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Geriatrics and Gerontology, 4 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Minne Casteels's work include Pharmaceutical Practices and Patient Outcomes (6 papers), Patient Safety and Medication Errors (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Minne Casteels is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (6 papers), Patient Safety and Medication Errors (4 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Minne Casteels collaborates with scholars based in Belgium, United Kingdom and United States. Minne Casteels's co-authors include Isabelle Huys, Paul P. Van Veldhoven, Myriam Baes, Serge Jennes, Daniël De Vos, Gilbert Verbeken, Peter Declercq, Jean‐Paul Pirnay, Rob Lavigne and Guy P. Mannaerts and has published in prestigious journals such as Nature Genetics, Biochemical Journal and Journal of Medical Internet Research.

In The Last Decade

Minne Casteels

20 papers receiving 545 citations

Peers

Countries citing papers authored by Minne Casteels

Since Specialization

Citations

This map shows the geographic impact of Minne Casteels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minne Casteels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minne Casteels more than expected).

Fields of papers citing papers by Minne Casteels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minne Casteels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minne Casteels. The network helps show where Minne Casteels may publish in the future.

Co-authorship network of co-authors of Minne Casteels

This figure shows the co-authorship network connecting the top 25 collaborators of Minne Casteels. A scholar is included among the top collaborators of Minne Casteels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minne Casteels. Minne Casteels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Prediction Model to Identify Clinically Relevant Medication Discrepancies at the Emergency Department (MED-REC Predictor): Development and Validation Study 2024 ·Journal of Medical Internet Research ·(unknown), Matthias Gijsen, Lorenz Van der Linden, (unknown), (unknown), (unknown), (unknown), (unknown), Veerle Foulon, Minne Casteels, Sandra Verelst, Peter Vanbrabant, Sabrina De Winter, Isabel Spriet	0
2	Bedside check of medication appropriateness (BED-CMA) as a risk-based tool for bedside clinical pharmacy services: A proof-of-concept study at the trauma surgery ward 2023 ·Computational and Structural Biotechnology Journal ·(unknown), (unknown), Peter Declercq, Willem‐Jan Metsemakers, An Sermon, Minne Casteels, Veerle Foulon, (unknown), Isabel Spriet	0
3	From basic to advanced computerised intravenous to oral switch for paracetamol and antibiotics: an interrupted time series analysis 2022 ·BMJ Open ·(unknown), (unknown), Peter Declercq, Minne Casteels, Willy Peetermans, Isabel Spriet	4
4	Home care nurses’ management of high-risk medications: a cross-sectional study 2022 ·Journal of Pharmaceutical Policy and Practice ·(unknown), Minne Casteels, Kristel De Vliegher, (unknown), Tinne Dilles	1
5	High-risk medication in community care: a scoping review 2020 ·European Journal of Clinical Pharmacology ·(unknown), Minne Casteels, Kristel De Vliegher, Tinne Dilles	6
6	Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective 2020 ·Frontiers in Medicine ·(unknown), Ciska Verbaanderd, Minne Casteels, Denis Lacombe, Isabelle Huys	8
7	Returning to Elective Orthopedic Surgery During the COVID-19 Pandemic: A Multidisciplinary and Pragmatic Strategy for Initial Patient Selection 2020 ·Journal of Patient Safety ·Georges Vles, (unknown), Iris De Ryck, Geert Meyfroidt, (unknown), Wouter Oosterlinck, Minne Casteels, Lieven Moke	4
8	Development and implementation of “Check of Medication Appropriateness” (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance 2019 ·BMC Medical Informatics and Decision Making ·(unknown), Thomas De Rijdt, (unknown), Steven Simoens, Willy Peetermans, Bart Van den Bosch, Minne Casteels, Isabel Spriet	36
9	Evaluation of real-life dosing of oral medicines with respect to fluid and food intake in a Dutch-speaking population 2017 ·Journal of Clinical Pharmacy and Therapeutics ·Bart Hens, Jens Van Den Αbeele, Jari Rubbens, (unknown), (unknown), (unknown), (unknown), Minne Casteels, Gert Laekeman, Patrick Augustijns	13
10	Sponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines 2015 ·BMC International Health and Human Rights ·Raffaella Ravinetto, Katelijne De Nys, Marleen Boelaert, Ermias Diro, Graeme Meintjes, Adoke Yeka, Harry Tagbor, Minne Casteels	15
11	Insights In European Drug Shortages: A Survey Of Hospital Pharmacists 2014 ·Value in Health ·Kim Pauwels, Steven Simoens, Minne Casteels, Isabelle Huys	2
12	Call for a Dedicated European Legal Framework for Bacteriophage Therapy 2014 ·Archivum Immunologiae et Therapiae Experimentalis ·Gilbert Verbeken, Jean‐Paul Pirnay, Rob Lavigne, Serge Jennes, Daniël De Vos, Minne Casteels, Isabelle Huys	67
13	Optimizing the European Regulatory Framework for Sustainable Bacteriophage Therapy in Human Medicine 2012 ·Archivum Immunologiae et Therapiae Experimentalis ·Gilbert Verbeken, Jean‐Paul Pirnay, Daniël De Vos, Serge Jennes, Martin Zizi, Rob Lavigne, Minne Casteels, Isabelle Huys	61
14	Osteoporosis after combined use of a neuroleptic and antidepressants 2008 ·Pharmacy World & Science ·Gert Laekeman, (unknown), (unknown), Marc A. Vos, Minne Casteels	8
15	Meropenem –valproic acid interaction in patients with cefepime-associated status epilepticus 2006 ·American Journal of Health-System Pharmacy ·Isabel Spriet, Wouter Meersseman, (unknown), Alexander Wilmer, Minne Casteels, Ludo Willems	28
16	Further insights into peroxisomal lipid breakdown via α- and β-oxidation 2001 ·Biochemical Society Transactions ·Paul P. Van Veldhoven, Minne Casteels, G P Mannaerts, Myriam Baes	12
17	Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse 2001 ·Biochemical Journal ·Steven Huyghe, Minne Casteels, (unknown), (unknown), Guy P. Mannaerts, Peter Declercq, Paul P. Van Veldhoven, Myriam Baes	22
18	A mouse model for Zellweger syndrome 1997 ·Nature Genetics ·Myriam Baes, Pierre Gressèns, Eveline Baumgart‐Vogt, Peter Carmeliet, Minne Casteels, Marc Fransen, Philippe Evrard, Dariush Fahimi, Peter Declercq, Désiré Collen, Paul P. Van Veldhoven, Guy P. Mannaerts	218
19	Activation and peroxisomal β-oxidation of fatty acids and bile acid intermediates in liver from Bombina orientalis and from the rat 1989 ·Comparative Biochemistry and Physiology Part B Comparative Biochemistry ·Minne Casteels, (unknown), G. Parmentier, H. Eyssen, (unknown)	4
20	Intussusception of the Vermiform Appendix 1986 ·Journal of Pediatric Gastroenterology and Nutrition ·Minne Casteels, E. Eggermont, Raymond Kerremans, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact